PDL BioPharma, Inc. Proceeds from Stock Options Exercised
PDL BioPharma, Inc. reported Proceeds from Stock Options Exercised of $700.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-03-29
- PDL BioPharma, Inc. proceeds from stock options exercised for the quarter ending 2019-12-31 was $0.00.
- PDL BioPharma, Inc. proceeds from stock options exercised for the quarter ending 2019-09-30 was $0.00.
- PDL BioPharma, Inc. proceeds from stock options exercised for fiscal 2020 was $700.00K.
- PDL BioPharma, Inc. proceeds from stock options exercised for fiscal 2019 was $0.00.
- PDL BioPharma, Inc. proceeds from stock options exercised for fiscal 2018 was $0.00.
- PDL BioPharma, Inc. proceeds from stock options exercised for fiscal 2009 was $1.40M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 8 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $700.00K 10-K · filed 2021-03-29 | ||||
| 2020-08-31 | $461.00K 10-K · filed 2021-03-29 | ||||
| 2020-06-30 | $461.00K 10-Q · filed 2020-08-07 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $0.00 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-07 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-29 | ||||
| 2009-12-31 | $1.40M 10-K · filed 2012-02-23 |